These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28960932)

  • 1. Heterologous erythromycin production across strain and plasmid construction.
    Fang L; Guell M; Church GM; Pfeifer BA
    Biotechnol Prog; 2018 Jan; 34(1):271-276. PubMed ID: 28960932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved heterologous erythromycin A production through expression plasmid re-design.
    Jiang M; Fang L; Pfeifer BA
    Biotechnol Prog; 2013; 29(4):862-9. PubMed ID: 23804312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The logic, experimental steps, and potential of heterologous natural product biosynthesis featuring the complex antibiotic erythromycin A produced through E. coli.
    Jiang M; Zhang H; Pfeifer BA
    J Vis Exp; 2013 Jan; (71):e4346. PubMed ID: 23354010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and performance of heterologous polyketide-producing K-12- and B-derived Escherichia coli.
    Wu J; Boghigian BA; Myint M; Zhang H; Zhang S; Pfeifer BA
    Lett Appl Microbiol; 2010 Aug; 51(2):196-204. PubMed ID: 20565574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved E. coli erythromycin A production through the application of metabolic and bioprocess engineering.
    Zhang H; Skalina K; Jiang M; Pfeifer BA
    Biotechnol Prog; 2012; 28(1):292-6. PubMed ID: 21905273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic and pathway engineering to influence native and altered erythromycin production through E. coli.
    Jiang M; Pfeifer BA
    Metab Eng; 2013 Sep; 19():42-9. PubMed ID: 23747605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host.
    Zhang H; Wang Y; Wu J; Skalina K; Pfeifer BA
    Chem Biol; 2010 Nov; 17(11):1232-40. PubMed ID: 21095573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving heterologous polyketide production in Escherichia coli by transporter engineering.
    Yang J; Xiong ZQ; Song SJ; Wang JF; Lv HJ; Wang Y
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8691-700. PubMed ID: 26062534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved precursor-directed biosynthesis in E. coli via directed evolution.
    Lee HY; Harvey CJ; Cane DE; Khosla C
    J Antibiot (Tokyo); 2011 Jan; 64(1):59-64. PubMed ID: 21081955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-deoxyerythronolide B production through chromosomal localization of the deoxyerythronolide B synthase genes in E. coli.
    Wang Y; Pfeifer BA
    Metab Eng; 2008 Jan; 10(1):33-8. PubMed ID: 17959404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring pathway modularity in the biosynthesis of erythromycin analogs heterologously engineered in E. coli.
    Zhang G; Li Y; Fang L; Pfeifer BA
    Sci Adv; 2015 May; 1(4):e1500077. PubMed ID: 26601183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadened glycosylation patterning of heterologously produced erythromycin.
    Fang L; Zhang G; El-Halfawy O; Simon M; Brown ED; Pfeifer BA
    Biotechnol Bioeng; 2018 Nov; 115(11):2771-2777. PubMed ID: 29873068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A.
    Zhou L; Ding Q; Jiang GZ; Liu ZN; Wang HY; Zhao GR
    Microb Cell Fact; 2017 May; 16(1):84. PubMed ID: 28511681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-encoded biosynthetic genes alleviate metabolic disadvantages while increasing glucose conversion to shikimate in an engineered Escherichia coli strain.
    Rodriguez A; Martínez JA; Millard P; Gosset G; Portais JC; Létisse F; Bolivar F
    Biotechnol Bioeng; 2017 Jun; 114(6):1319-1330. PubMed ID: 28186321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the heterologous metabolism supporting 6-deoxyerythronolide B biosynthesis in Escherichia coli.
    Zhang H; Wang Y; Boghigian B; Pfeifer BA
    Microb Biotechnol; 2009 May; 2(3):390-4. PubMed ID: 21261933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Continuing Development of E. coli as a Heterologous Host for Complex Natural Product Biosynthesis.
    Zhang H; Fang L; Osburne MS; Pfeifer BA
    Methods Mol Biol; 2016; 1401():121-34. PubMed ID: 26831705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of polyketide overproducing Escherichia coli strains via synthetic antisense RNAs based on in silico fluxome analysis and comparative transcriptome analysis.
    Meng HL; Xiong ZQ; Song SJ; Wang J; Wang Y
    Biotechnol J; 2016 Mar; 11(4):530-41. PubMed ID: 26709503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Biosynthetic Pathway for the Production of Acrylic Acid through β-Alanine Route in
    Ko YS; Kim JW; Chae TU; Song CW; Lee SY
    ACS Synth Biol; 2020 May; 9(5):1150-1159. PubMed ID: 32243749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous biosynthesis of triterpenoid ambrein in engineered Escherichia coli.
    Ke D; Caiyin Q; Zhao F; Liu T; Lu W
    Biotechnol Lett; 2018 Feb; 40(2):399-404. PubMed ID: 29204767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular variation of the nonribosomal peptide-polyketide siderophore yersiniabactin through biosynthetic and metabolic engineering.
    Ahmadi MK; Fawaz S; Fang L; Yu Z; Pfeifer BA
    Biotechnol Bioeng; 2016 May; 113(5):1067-74. PubMed ID: 26524346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.